Results 181 to 190 of about 3,417,285 (304)
ABSTRACT The global refugee population has nearly doubled in the last decade, and many of these populations face chronic displacement, often in neighbouring countries with limited resources. Emergency, short‐term responses are being transitioned to longer term approaches, including a focus on inclusion through coverage in national health systems ...
Sophie Witter +13 more
wiley +1 more source
Factors associated with inpatient medical record data quality in hospital settings: a systematic review. [PDF]
Liao P +5 more
europepmc +1 more source
ABSTRACT Publicly financed healthcare systems must balance technological innovation with fiscal constraints. Reimbursement mechanisms influence institutional decisions regarding the adoption of high‐cost surgical technologies. This study evaluated whether current reimbursement designs adequately reflect procedure‐level gross surgical profit of robot ...
Yoshimasa Akashi +8 more
wiley +1 more source
From Joint Clinical Assessment to National Decisions: EU HTA Implementation and Implications for Patient Access. [PDF]
D'Oca K +3 more
europepmc +1 more source
ABSTRACT Trust in childhood vaccination is a concern for health policy, particularly in settings of political transition and conflict, where governance, institutional legitimacy and service delivery are often under strain. It is against this backdrop that this study aims to describe evolving interactions between health system governance, trust and ...
Harriet Dwyer +7 more
wiley +1 more source
Physicians' Perspectives on Access to Innovative Oncology Therapies: A Cross-Sectional Survey in Bulgaria. [PDF]
Zdravkova-Aneva I +5 more
europepmc +1 more source
ABSTRACT Health Technology Assessment (HTA) is an organizational process used to determine the value of health‐technologies. There is considerable variation in how HTA is developed globally, with Canada at the forefront of this field, having pioneered the use of HTA and implemented it extensively across healthcare organisations at all levels.
Salvatore Tallarico +3 more
wiley +1 more source
Asia-Pacific analysis of ESMO study on availability, out-of-pocket costs (OPC) and accessibility of antineoplastic medicines. [PDF]
Wong ANM +19 more
europepmc +1 more source

